Table 1 Preoperative data of the two patient groups
Variables | Group survivor (n = 505) | Group non-survivor (n = 52) | P value |
---|---|---|---|
Male, n (%) | 377 (74.7) | 38 (73.1) | 0.804 |
Age, n (year) | 52.0 (45.0, 61.0) | 59.0 (51.0, 64.0) | <0.001 |
Body mass index (Kg/M2) | 25.7 ± 4.0 | 26.3 ± 4.2 | 0.289 |
BUN (mmol/L) | 5.20 (4.3, 7.00) | 8.65 (585, 11.50) | <0.001 |
SA (g/L) | 38.0 ± 4.0 | 35.8 ± 4.2 | <0.001 |
BA-R (mmol/g) | 0.14(0.11, 0.19) | 0.27(0.18, 0.45) | <0.001 |
Serum creatinine (umol/L) | 77.0 (65.0, 108.0) | 94.0 (71.5, 134.3) | 0.018 |
D-Dimer(ug/mL) | 7.55 (3.46, 18.40) | 17.70 (9.02, 20.0) | <0.001 |
Leukocyte (10ˆ9/L) | 12.1 (9.3, 14.3) | 12.4 (9.2, 15.7) | 0.415 |
Platelet (10ˆ9/L) | 199.1 ± 72.9 | 203.2 ± 70.1 | 0.701 |
Prothrombin time(sec) | 13.8 (13.2, 14.6) | 13.9 (13.4, 15.2) | 0.537 |
Heamoglobin (g/L) | 129.7 ± 21.1 | 127.4 ± 19.6 | 0.449 |
Troponin-I (ug/L) | 0.6 ± 3.0 | 0.7 ± 2.3 | 0.765 |
NT-ProBNP (pg/mL) | 278 (150.5, 591.0) | 288 (163.0, 847.0) | 0.523 |
Lactic acid (mmol/L) | 1.59 ± 0.89 | 1.94 ± 1.35 | 0.012 |
Alanine aminotransferase (IU/L) | 26.0 (18.0, 43.0) | 28.0 (21.0, 53.5) | 0.447 |
Aspartate aminotransferase (IU/L) | 27.0 (19.0, 46.0) | 28.0 (19.5, 67.0) | 0.431 |
LVEF (%) | 63.6 ± 6.9 | 62.6 ± 6.1 | 0.312 |
Hypertension, n (%) | 388 (76.8) | 42 (88.8) | 0.519 |
Diabetes, n (%) | 38 (7.5) | 2 (3.8) | 0.486 |
Coronary heart disease, n (%) | 45 (89.1) | 6 (11.5) | 0.532 |
COPD, n (%) | 15 (3.0) | 2 (3.8) | 0.941 |
Acute renal insufficiency | 37 (7.3) | 7 (13.5) | 0.118 |
Myocardial ischemia | 14 (2.8) | 4 (7.7) | 0.134 |
Cerebral ischemia | 12 (2.4) | 4 (7.7) | 0.080 |
AR(Medium or above), n (%) | 60 (11.9) | 7 (13.5) | 0.739 |